Industry News
Hydrogel to enable tumour-targeting cancer treatment
Researchers have developed a 3D-printable material that opens the way to personalised cancer treatment by enabling multiple, simultaneous tests to find the correct therapy to target a particular tumour. [ + ]
$1 million for radiopharma company
Clarity Pharmaceuticals is one of 15 lucky companies that this month received grant funding through Accelerating Commercialisation. [ + ]
Dendrimer technology licensed for herbicide
Starpharma's Priostar dendrimer technology has been licensed for the development of an enhanced 2,4-D herbicide for the US market. [ + ]
Working together to unleash killer T cells
Researchers have discovered how two pathways cooperate to unleash the immune system's assassins, called cytotoxic or 'killer' T cells. [ + ]
Dedicated cancer research centre opening soon
The Centenary Institute and the ACRF have announced the first dedicated cancer research centre in the RPA Hospital and University of Sydney precinct. [ + ]
Entries now open for 2016 Eureka Prizes
Australian researchers, science leaders and science journalists are invited to enter the 2016 Australian Museum Eureka Prizes. [ + ]
Building the next generation of STEM
Women in Technology (WiT) is launching STEMed — a one-day festival of education for the future. [ + ]
Positive data from bladder cancer trial
Viralytics announced positive data from a clinical trial of its lead drug candidate, CAVATAK, at the 31st Annual European Association of Urology Congress held in Munich. [ + ]
POC diagnostics market to reach almost $3 billion by 2021
GlobalData has projected that the point-of-care (POC) diagnostics market will experience solid growth from $2.13 billion in 2015 to just under $3 billion by 2021, representing a compound annual growth rate (CAGR) of 5.3%. [ + ]
Call for increased research-business collaboration
Bill Ferris AC has told Australia's university leaders that increasing collaboration for commercialisation of research is both desirable and achievable. [ + ]
Blood pressure drug boosts the effect of chemo
Scientists have discovered that a drug developed to treat high blood pressure has a powerful 'chemo-boosting' effect when combined with certain chemotherapeutic drugs for the treatment of angiosarcoma. [ + ]
Innovation fund attracting foreign investment, says fund manager
The Prime Minister's $500 million innovation fund has already attracted significant international interest and will attract offshore investment to the country, according to life sciences fund manager Jeremy Curnock Cook. [ + ]
Danielle Butcher joins Science Industry Australia board
Science Industry Australia (SIA) has announced Danielle Butcher as the new executive officer of its board of directors. [ + ]
Hobart hosts international ice core scientists
The International Partnerships in Ice Core Sciences (IPICS) Second Open Science Conference has begun. [ + ]
Melbourne's Bio21 Institute is expanding
Prime Minister Malcolm Turnbull has announced the imminent expansion of The University of Melbourne's Bio21 Molecular Science and Biotechnology Institute. [ + ]

